Skip to main content
Erschienen in: European Child & Adolescent Psychiatry 1/2019

09.05.2018 | Letter to the Editor

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder

verfasst von: Erlend Glasø Faltinsen, Ole Jakob Storebø, Christian Gluud

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

We thank Padilha and colleagues for their network meta-analysis on efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents [1]. The network meta-analysis looks comprehensive and the results are interesting. We invite readers to consider the following potential limitations of the study. …
Literatur
3.
Zurück zum Zitat Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y et al (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 391(10128):1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7 CrossRef Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y et al (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 391(10128):1357–1366. https://​doi.​org/​10.​1016/​S0140-6736(17)32802-7 CrossRef
5.
Zurück zum Zitat Higgins JPT, Altman DG, Sterne JAC (eds) (2017) Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (eds) Cochrane handbook for systematic reviews of interventions version 5.2.0 [updated June 2017]. Cochrane. http://www.training.cochrane.org/handbook Higgins JPT, Altman DG, Sterne JAC (eds) (2017) Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (eds) Cochrane handbook for systematic reviews of interventions version 5.2.0 [updated June 2017]. Cochrane. http://​www.​training.​cochrane.​org/​handbook
6.
Zurück zum Zitat Rodrigues-Tartari R, Swardfager W, Salum GA, Rohde LA, Cogo-Moreira H (2018) Assessing risk of bias in randomized controlled trials of methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Int J Methods Psychiatr Res 27:e1586. https://doi.org/10.1002/mpr.1586 CrossRef Rodrigues-Tartari R, Swardfager W, Salum GA, Rohde LA, Cogo-Moreira H (2018) Assessing risk of bias in randomized controlled trials of methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Int J Methods Psychiatr Res 27:e1586. https://​doi.​org/​10.​1002/​mpr.​1586 CrossRef
Metadaten
Titel
Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder
verfasst von
Erlend Glasø Faltinsen
Ole Jakob Storebø
Christian Gluud
Publikationsdatum
09.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 1/2019
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-018-1164-6

Weitere Artikel der Ausgabe 1/2019

European Child & Adolescent Psychiatry 1/2019 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.